PUBLISHER: Orion Market Research | PRODUCT CODE: 1064847
PUBLISHER: Orion Market Research | PRODUCT CODE: 1064847
Global QX Chloride Market Size, Share & Trends Analysis Report By Type (High Purity (Above 99%), Low Purity (Below 97%), Purity (Above 97% and Below 99%)), By Application (Medical Treatment, Bioscience Research, Others), Forecast (2021 - 2027).
The global QX chloride market is anticipated to grow at a considerable CAGR during the forecast period. QX chloride is an amino amide local anesthetic which is being used for treatment of skin irritations such as burns, scratches, small cuts, poison sumac, poison oak, poison ivy, bug bites, and sunburns. It is also used to treat ventricular tachycardia. When used for a nerve block or local anesthetic, it begins to act within a few minutes and lasts for 30 minutes to three hours. Rising application in dental procedures, rising prevalence of periodontal disorders, and increased implementations of dental carriers are some factors which led to the market expansion.
The global QX chloride market is segmented based on type and application. Based on type, the QX chloride market is segmented into high purity (above 99%), low purity (below 97%), purity (above 97% and below 99%) QX chloride. Based on application, the QX chloride market is segmented into medical treatment, bioscience research, and others.
Geographically, the global QX chloride market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global QX chloride market include R&D Systems, Inc., Anward, Cayman Chemical Co., Abcam Plc, Alfa Chemistry, Stemgent, Inc., and STEMCELL Technologies Inc. among others.
Market Segmentation
The Report Covers